Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and lovastatin

resveratrol has been researched along with lovastatin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Sashidhara, KV; Singh, SP1
Choi, MS; Jeon, SM; Lee, SA1
Bisen, PS; Bundela, S; Sharma, A1
Awad, E; Othman, EM; Stopper, H1
Attalah Nee Rezkallah, C; Chen, QM; Thongkum, A; Zhu, C1

Reviews

1 review(s) available for resveratrol and lovastatin

ArticleYear
Lipid lowering agents of natural origin: An account of some promising chemotypes.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents

2017

Other Studies

5 other study(ies) available for resveratrol and lovastatin

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.
    Journal of medicinal food, 2014, Volume: 17, Issue:3

    Topics: Animals; Anti-Obesity Agents; Anticholesteremic Agents; Aorta; Apolipoproteins E; Arteriosclerosis; Diet, Atherogenic; Humans; Lovastatin; Male; Mice; Mice, Knockout; Obesity; Protective Agents; Resveratrol; Stilbenes

2014
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat

2015
Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro.
    Molecules (Basel, Switzerland), 2017, Dec-12, Volume: 22, Issue:12

    Topics: Animals; Cell Survival; Cells, Cultured; Diabetes Mellitus; DNA Damage; Epithelial Cells; Everolimus; Humans; Insulin; Kidney; Lovastatin; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases

2017
Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:6

    Topics: Animals; Atorvastatin; Caspase 3; Caspase 7; Cell Line; Cell Survival; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Myoblasts; Pravastatin; Protective Agents; Rats; Resveratrol; Signal Transduction; Simvastatin

2020